logo
logo

Elixirgen Therapeutics, Inc. announced it raised $4.2 Million in an initial filing from an offering of $5.5 Million

Feb 18, 2021•over 4 years ago

Amount Raised

$4.2 Million

BaltimoreBiotechnology

Company Information

Company

Elixirgen Therapeutics

Location

855 N. WOLFE ST.

Baltimore, Maryland, United States

About

Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.

Related People